Anthony S. Ridolfo

873 total citations
31 papers, 687 citations indexed

About

Anthony S. Ridolfo is a scholar working on Pharmacology, Analytical Chemistry and Oncology. According to data from OpenAlex, Anthony S. Ridolfo has authored 31 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Analytical Chemistry and 5 papers in Oncology. Recurrent topics in Anthony S. Ridolfo's work include Inflammatory mediators and NSAID effects (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Analytical Chemistry and Chromatography (3 papers). Anthony S. Ridolfo is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Analytical Chemistry and Chromatography (3 papers). Anthony S. Ridolfo collaborates with scholars based in United States and Denmark. Anthony S. Ridolfo's co-authors include R Nickander, F. Gilbert McMahon, Charles M. Gruber, Alan Rubin, Bruce E. Rodda, Robert L. Wolen, Charlés Fisch, Frederick J. Marshall, Robert E. McMahon and Hilman W. Culp and has published in prestigious journals such as Circulation, Diabetes and The American Journal of Medicine.

In The Last Decade

Anthony S. Ridolfo

30 papers receiving 547 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anthony S. Ridolfo 258 188 85 83 82 31 687
Richard Runkel 344 1.3× 175 0.9× 78 0.9× 81 1.0× 115 1.4× 16 626
Hilli Sevelius 543 2.1× 196 1.0× 71 0.8× 110 1.3× 111 1.4× 31 1.0k
Tamehiro Tsuchiya 168 0.7× 214 1.1× 56 0.7× 100 1.2× 103 1.3× 19 638
Thomas M. Twomey 269 1.0× 146 0.8× 64 0.8× 182 2.2× 178 2.2× 20 730
Donald C. Hobbs 223 0.9× 135 0.7× 69 0.8× 161 1.9× 179 2.2× 29 686
Suk Han Wan 125 0.5× 117 0.6× 77 0.9× 125 1.5× 88 1.1× 22 819
G. Heinzel 391 1.5× 211 1.1× 63 0.7× 156 1.9× 74 0.9× 31 913
M. D. Chaplin 361 1.4× 311 1.7× 91 1.1× 186 2.2× 105 1.3× 36 1.1k
J.P. Desager 121 0.5× 173 0.9× 68 0.8× 130 1.6× 73 0.9× 68 1.1k
B. K. MARTIN 150 0.6× 218 1.2× 92 1.1× 184 2.2× 93 1.1× 35 673

Countries citing papers authored by Anthony S. Ridolfo

Since Specialization
Citations

This map shows the geographic impact of Anthony S. Ridolfo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony S. Ridolfo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony S. Ridolfo more than expected).

Fields of papers citing papers by Anthony S. Ridolfo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony S. Ridolfo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony S. Ridolfo. The network helps show where Anthony S. Ridolfo may publish in the future.

Co-authorship network of co-authors of Anthony S. Ridolfo

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony S. Ridolfo. A scholar is included among the top collaborators of Anthony S. Ridolfo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony S. Ridolfo. Anthony S. Ridolfo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ridolfo, Anthony S., et al.. (1982). Clinical pharmacology of benoxaprofen.. PubMed. 5(2). 98–112. 5 indexed citations
2.
Ridolfo, Anthony S., et al.. (1979). STEREOSELECTIVE INVERSION OF (R)-(–)-BENOXAPROFEN TO THE (S)-(+)-ENANTIOMER IN HUMANS. Drug Metabolism and Disposition. 7(6). 356–359. 54 indexed citations
3.
Yum, Moo Nahm, et al.. (1979). Pseudolymphoma of the lung in a patient with systemic lupus erythematosus. The American Journal of Medicine. 66(1). 172–176. 25 indexed citations
4.
Nickander, R, F. Gilbert McMahon, & Anthony S. Ridolfo. (1979). Nonsteroidal Anti-Inflammatory Agents. The Annual Review of Pharmacology and Toxicology. 19(1). 469–490. 135 indexed citations
5.
Wolen, Robert L., et al.. (1979). The effect of crystal size on the bioavailability of benoxaprofen: Studies utilizing deuterium labeled drug. Journal of Mass Spectrometry. 6(4). 173–178. 18 indexed citations
6.
Ridolfo, Anthony S., et al.. (1979). Fenoprofen and Benoxaprofen. Clinics in Rheumatic Diseases. 5(2). 393–410. 8 indexed citations
7.
Park, Hee‐Myung, et al.. (1977). A quantitative evaluation of rheumatoid arthritic activity with Tc-99m HEDP.. PubMed. 18(10). 973–6. 16 indexed citations
8.
Sigler, John W., Anthony S. Ridolfo, & Gilbert B. Bluhm. (1976). Comparison of benefit-to-risk ratios of aspirin and fenoprofen: controlled multicentre study in rheumatoid arthritis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2. 49–60. 13 indexed citations
9.
Murphy, P. J., et al.. (1975). Metabolism of propionyl erythromycin lauryl sulfate. II. Fate of the lauryl sulfate moiety in the rat and man.. PubMed. 3(3). 164–70. 2 indexed citations
10.
Rubin, Alan, et al.. (1974). A PHARMACOKINETIC INTERACTION IN MAN BETWEEN PHENOBARBITONE AND FENOPROFEN, A NEW ANTI‐INFLAMMATORY AGENT. British Journal of Clinical Pharmacology. 1(5). 371–374. 17 indexed citations
11.
Ridolfo, Anthony S., et al.. (1973). Screening rapidly acting anti-inflammatory agents in patients with rheumatoid arthritis. The American Journal of the Medical Sciences. 265(5). 375–379. 9 indexed citations
12.
Crabtree, Ross E., et al.. (1973). Tracer microspheres as a fecal marker in balance studies. Clinical Pharmacology & Therapeutics. 14(6). 987–991. 5 indexed citations
13.
Rubin, Alan, et al.. (1972). PHYSIOLOGICAL DISPOSITION OF FENOPROFEN IN MAN. III. METABOLISM AND PROTEIN BINDING OF FENOPROFEN. Journal of Pharmacology and Experimental Therapeutics. 183(2). 449–457. 15 indexed citations
14.
Rubin, Alan, et al.. (1972). Physiological Disposition of Fenoprofen in Man II: Plasma and Urine Pharmacokinetics after Oral and Intravenous Administration. Journal of Pharmaceutical Sciences. 61(5). 739–745. 30 indexed citations
15.
Rubin, Alan, et al.. (1971). Physiological Disposition of Fenoprofen in Man I: Pharmacokinetic Comparison of Calcium and Sodium Salts Administered Orally. Journal of Pharmaceutical Sciences. 60(12). 1797–1801. 22 indexed citations
16.
Ridolfo, Anthony S., et al.. (1960). The Skin-surface-glucose Test: An Aid in the Diagnosis of Diabetes Mellitus. Diabetes. 9(1). 48–52. 5 indexed citations
17.
Gruber, Charles M., et al.. (1958). An Enteric Compression Coating II**Lilly Laboratory for Clinical Research and the X-ray Department, Indianapolis General Hospital, Indianapolis, Ind.. Journal of the American Pharmaceutical Association (Scientific ed ). 47(12). 862–866. 7 indexed citations
18.
Fisch, Charlés & Anthony S. Ridolfo. (1958). Reverse Wenckebach Block and Complete Atrioventricular Dissociation due to Potassium and Digitalis. Circulation. 18(5). 852–855. 27 indexed citations
19.
Gruber, Charles M., Anthony S. Ridolfo, & R. S. Griffith. (1958). An Enteric Compression Coating III**Lilly Laboratory for Clinical Research, Indianapolis General Hospital, Indianapolis, Ind.. Journal of the American Pharmaceutical Association (Scientific ed ). 47(12). 867–869. 1 indexed citations
20.
Ridolfo, Anthony S.. (1956). CLINICAL EXPERIENCES WITH CARBUTAMIDE, AN ORALLY GIVEN HYPOGLYCEMIC AGENT. Journal of the American Medical Association. 160(15). 1285–1285. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Runkel Breakdown of academic impact, for papers by Hilli Sevelius Breakdown of academic impact, for papers by Tamehiro Tsuchiya Breakdown of academic impact, for papers by Thomas M. Twomey Breakdown of academic impact, for papers by Donald C. Hobbs Breakdown of academic impact, for papers by Suk Han Wan Breakdown of academic impact, for papers by G. Heinzel Breakdown of academic impact, for papers by M. D. Chaplin Breakdown of academic impact, for papers by J.P. Desager Breakdown of academic impact, for papers by B. K. MARTIN
Rankless by CCL
2026